help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 50, No. 6 1089-1093
doi:10.1210/jcem-50-6-1089
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HAMBURGER, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HAMBURGER, J. I.

Evolution of Toxicity in Solitary Nontoxic Autonomously Functioning Thyroid Nodules

JOEL I. HAMBURGER

20905 Greenfield, Southfield, Michigan 48075

Address requests for reprints to: Dr. Joel I. Hamburger, 20905 Greenfield, Suite300, Southfield, Michigan 48075.

Between 1961 and 1979, 349 patients with autonomously functioning thyroid nodules (AFTN) were seen. There were 287 nontoxic and 62 toxic lesions. Toxic lesions were seen in 56.5% of AFTN patients over 60 yr of age but in only 12.5% of the younger patients. The female to male ratio was 14.9:1 for nontoxic AFTN patients but only 5.9:1 for toxic AFTN patients. The proportion of toxic AFTN in patients less than 20 yr old (13.8%) was not significantly different from that in patients 20–60 yr old (12.7%). T3 toxicosis was observed in 46% of those patients with hyperthyroidism. All but 4 of the toxic AFTN measured 3 cm in diameter or larger. AFTN 3 cm or larger were more than twice as common in patients 40 yr or older than in younger patients. Of 159 untreated nontoxic AFTN patients, 14 became toxic within 1–6 yr. One patient in 5 with a nontoxic AFTN 3 cm or larger developed toxicity.

Received November 9, 1979.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Moreno-Reyes, B.-N.-T. Tang, A. Seret, S. Goldman, C. Daumerie, and B. Corvilain
Impaired Iodide Organification in Autonomous Thyroid Nodules
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4719 - 4724.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke
Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
Endocr. Rev., June 1, 2005; 26(4): 504 - 524.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. Hegedus
The Thyroid Nodule
N. Engl. J. Med., October 21, 2004; 351(17): 1764 - 1771.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Hegedus, S. J. Bonnema, and F. N. Bennedbaek
Management of Simple Nodular Goiter: Current Status and Future Perspectives
Endocr. Rev., February 1, 2003; 24(1): 102 - 132.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
B. Biondi, E. A. Palmieri, G. Lombardi, and S. Fazio
Effects of Subclinical Thyroid Dysfunction on the Heart
Ann Intern Med, December 3, 2002; 137(11): 904 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Biondi, E. A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Saccà, S. Filetti, G. Lombardi, and F. Perticone
Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4701 - 4705.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Aghini-Lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, et al.
The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 561 - 566.
[Abstract] [Full Text]


Home page
NEJMHome page
A. R. Hermus and D. A. Huysmans
Treatment of Benign Nodular Thyroid Disease
N. Engl. J. Med., May 14, 1998; 338(20): 1438 - 1447.
[Full Text] [PDF]


Home page
NEJMHome page
R. Paschke and M. Ludgate
The Thyrotropin Receptor in Thyroid Diseases
N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681.
[Full Text] [PDF]


Home page
Arch Fam MedHome page
L. R. Petrone
A Primary Care Approach to the Adult Patient With Nodular Thyroid Disease
Arch Fam Med, February 1, 1996; 5(2): 92 - 100.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
P. A. Clark, B. M. Rogers, and A. D. Rogol
Radiological Case of the Month
Arch Pediatr Adolesc Med, June 1, 1995; 149(6): 697 - 698.
[Abstract] [PDF]


Home page
NEJMHome page
E. L. Mazzaferri
Management of a Solitary Thyroid Nodule
N. Engl. J. Med., February 25, 1993; 328(8): 553 - 559.
[Full Text]


Home page
ANN INTERN MEDHome page
J. I. HAMBURGER
The Various Presentations of Thyroiditis: Diagnostic Considerations
Ann Intern Med, February 1, 1986; 104(2): 219 - 224.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
H. B. Hahn Jr, J. F. McKenney Jr, and J. C. Stinson
Nodular Toxic Goiter in a Teenage Girl
Arch Pediatr Adolesc Med, September 1, 1982; 136(9): 849 - 851.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society